Evidence map›Paper›PMID 35722018›Full record

ArticleACS omega2022

Direct Crystallization Resolution of Racemates Enhanced by Chiral Nanorods: Experimental, Statistical, and Quantum Mechanics/Molecular Dynamics Simulation Studies.

Jiaojiao Cao, Boxuan Lou, Yue Xu, Xiaolan Qin, Haikuan Yuan, Lijuan Zhang, Yan Zhang, Sohrab Rohani, Jie Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Sequential Amplification of Amino Acid Enantiomeric Excess by Conglomerate and Racemic Compound: Plausible Prebiotic Route Towards Homochirality.Origins of life and evolution of the biosphere : the journal of the International Society for the Study of the Origin of Life · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiaojiao CaoChemical Engineering Department, Frontier Medical Technologies Institute, Shanghai University of Engineering Science, Shanghai 201620, China.
Boxuan LouChemical Engineering Department, Frontier Medical Technologies Institute, Shanghai University of Engineering Science, Shanghai 201620, China.
Yue XuChemical Engineering Department, Frontier Medical Technologies Institute, Shanghai University of Engineering Science, Shanghai 201620, China.
Xiaolan QinChemical Engineering Department, Frontier Medical Technologies Institute, Shanghai University of Engineering Science, Shanghai 201620, China.
Haikuan YuanChemical Engineering Department, Frontier Medical Technologies Institute, Shanghai University of Engineering Science, Shanghai 201620, China.
Lijuan ZhangChemical Engineering Department, Frontier Medical Technologies Institute, Shanghai University of Engineering Science, Shanghai 201620, China.
Yan ZhangDepartment of Process Engineering, Memorial University of Newfoundland, St John's NL A1B 3X5, Canada.ORCID https://orcid.org/0000-0003-0107-1014
Sohrab RohaniDepartment of Chemical and Biochemical Engineering, Western University, London N6A 5B9, Canada.ORCID https://orcid.org/0000-0002-1667-1736
Jie LuChemical Engineering Department, Frontier Medical Technologies Institute, Shanghai University of Engineering Science, Shanghai 201620, China.ORCID https://orcid.org/0000-0002-4581-2032

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three chiral nanorods of C

Identifiers

PMID35722018
PMCPMC9202296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.